Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Naive B Cell Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03980002
What this trial is testing

A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07508995
What this trial is testing

Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT06530511
What this trial is testing

Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Affiliated Hospital of Nantong University 30
Large-scale testing (Phase 3)Study completedNCT03263026
What this trial is testing

Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™

Who this might be right for
Diffuse Large B-Cell Lymphoma
Denovo Biopharma LLC 256
Testing effectiveness (Phase 2)Active Not RecruitingNCT04460248
What this trial is testing

Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02825836
What this trial is testing

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Who this might be right for
Relapsed/Refractory B Cell MalignanciesMantle Cell Lymphoma and Diffuse Large B Cell LymphomaChronic Lymphocytic Leukemia+2 more
Telios Pharma, Inc. 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03620903
What this trial is testing

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Christian Buske 53
Early research (Phase 1)Study completedNCT03447808
What this trial is testing

Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Jennifer Woyach 15
Early research (Phase 1)UnknownNCT01976520
What this trial is testing

Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
XEME Biopharma Inc. 30